Manufacturer record
Jakson Laboratories Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Jakson Laboratories Pvt. Ltd (Punjab) were declared Not of Standard Quality between February 2023 and September 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Jakson Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Moxifloxacin & Dexamethasone Eye Drops (Moxiflox-D Eye Drops) | ED-1518Mfg 2023-08 · Exp 2025-07 | Assay of Moxifloxacin Hydrochlorid eAssay | CDL KolkataCDSCO lab | Sep 2023 |
| Caffeine Citrate Injection USP 60mg/3ml | I-5735Mfg 2022-12 · Exp 2024-11 | Sterility & Bacterial EndotoxinsSterility | CDL KolkataCDSCO lab | Sep 2023 |
| Ambroxol HCL, Terbutaline Sulphate & Guaiphensin Expectorant (Viscoril- AP) | SY-6953Mfg 2023-03 · Exp 2025-02 | Assay of Ambroxol Hydrochlorid e & Terbutaline SulphateAssay | CDL KolkataCDSCO lab | Sep 2023 |
| DIVIRON-SR (Diclofenac Prolonged Release Tablets I.P. 100mg) | T-2387Mfg 2021-12 · Exp 2023-11 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.